Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2018-01-16 Sale | 2018-01-18 9:30 pm | Juno Therapeutics Inc. | JUNO | Bishop Hans Edgar CEO | 270,250 | $46.17 | $12,478,528 | 2,954,185 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-04-05 Option Award | 2022-04-06 5:55 pm | N/A N/A | Sana Biotechnology Inc. | SANA | Bishop Hans Edgar Director | 2,880 | $0 | 5,739,130 (Direct) | View |
2022-03-17 Option Award | 2022-03-21 5:03 pm | N/A N/A | AGILENT TECHNOLOGIES Inc | A | Bishop Hans Edgar Director | 2,582 | $136.82 | 19,853 (Direct) | View |
2022-02-23 Exercise | 2022-02-25 4:05 pm | N/A 2028-11-05 | Lyell Immunopharma Inc. | LYEL | Bishop Hans Edgar Director | 993,428 | $0 | 4,709,844 (Direct) | View |
2022-02-23 Exercise | 2022-02-25 4:05 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Bishop Hans Edgar Director | 993,428 | $0.1 | 4,709,844 (Direct) | View |
2021-06-21 Conversion | 2021-06-23 5:35 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Bishop Hans Edgar Director | 546,806 | $0 | 3,546,806 (Direct) | View |
2021-06-16 Ownership | 2021-06-16 7:12 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | Bishop Hans Edgar Director | 0 | $0 | 4,709,844 (Direct) | View |
2021-03-18 Option Award | 2021-03-22 3:14 pm | N/A N/A | AGILENT TECHNOLOGIES Inc | A | Bishop Hans Edgar Director | 2,672 | $121.59 | 17,176 (Direct) | View |
2021-02-03(A) Option Award | 2021-02-18 7:02 pm | N/A 2031-02-02 | Sana Biotechnology Inc. | SANA | Bishop Hans Edgar Director | 23,591 | $0 | 23,591 (Direct) | View |
2021-02-08 Conversion | 2021-02-10 7:00 pm | N/A N/A | Sana Biotechnology Inc. | SANA | Bishop Hans Edgar Director | 4,062,500 | $0 | 5,736,250 (Direct) | View |
2021-02-03 Option Award | 2021-02-05 5:21 pm | N/A 2031-02-02 | Sana Biotechnology Inc. | SANA | Bishop Hans Edgar Director | 14,000 | $0 | 14,000 (Direct) | View |
2021-02-03 Ownership | 2021-02-03 8:10 pm | N/A N/A | Sana Biotechnology Inc. | SANA | Bishop Hans Edgar Director | 0 | $0 | 5,736,250 (Direct) | View |
2020-08-03 Option Award | 2020-08-05 6:30 pm | N/A N/A | AGILENT TECHNOLOGIES Inc | A | Bishop Hans Edgar Director | 177 | $93.91 | 14,456 (Direct) | View |
2020-04-17 Option Award | 2020-04-21 7:32 pm | N/A N/A | AGILENT TECHNOLOGIES Inc | A | Bishop Hans Edgar Director | 4,108 | $73.01 | 14,228 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:30 am | N/A 2028-04-18 | CELGENE CORP | CELG | Bishop Hans Edgar Director | 52,564 | $0 | 0 (Direct) | View |
2019-06-03 Option Award | 2019-06-05 4:05 pm | N/A N/A | CELGENE CORP | CELG | Bishop Hans Edgar Director | 4,756 | $0 | 4,756 (Direct) | View |
2019-03-21 Option Award | 2019-03-22 2:20 pm | N/A N/A | AGILENT TECHNOLOGIES INC | A | Bishop Hans Edgar Director | 3,450 | $82 | 10,032 (Direct) | View |
2018-06-13 Option Award | 2018-06-15 4:27 pm | N/A 2028-06-13 | CELGENE CORP | CELG | Bishop Hans Edgar Director | 14,720 | $0 | 14,720 (Direct) | View |
2018-04-18 Ownership | 2018-04-19 4:03 pm | N/A N/A | CELGENE CORP | CELG | Bishop Hans Edgar Director | 0 | $0 | 33,088 (Direct) | View |
2018-03-22 Option Award | 2018-03-23 6:27 pm | N/A N/A | AGILENT TECHNOLOGIES INC | A | Bishop Hans Edgar Director | 4,314 | $67.47 | 6,522 (Direct) | View |
2018-03-05 Disposition | 2018-03-07 6:15 pm | N/A 2024-09-08 | Juno Therapeutics Inc. | JUNO | Bishop Hans Edgar CEO | 1,133,031 | $0 | 0 (Direct) | View |
2018-03-05 Equity Swap | 2018-03-07 6:15 pm | N/A N/A | Juno Therapeutics Inc. | JUNO | Bishop Hans Edgar CEO | 2,263,948 | $87 | 0 (Direct) | View |
2018-03-05 Disposition | 2018-03-07 6:15 pm | N/A N/A | Juno Therapeutics Inc. | JUNO | Bishop Hans Edgar CEO | 48,829 | $87 | 0 (Direct) | View |
2018-02-07 Tax Withholding | 2018-02-09 7:29 pm | N/A N/A | Juno Therapeutics Inc. | JUNO | Bishop Hans Edgar CEO | 4,346 | $85.49 | 2,448,229 (Direct) | View |
2018-02-07 Gift | 2018-02-09 7:29 pm | N/A N/A | Juno Therapeutics Inc. | JUNO | Bishop Hans Edgar CEO | 116,280 | $0 | 2,448,229 (Direct) | View |
2018-01-31 Option Award | 2018-02-02 7:28 pm | N/A N/A | Juno Therapeutics Inc. | JUNO | Bishop Hans Edgar CEO | 66,426 | $0 | 2,568,855 (Direct) | View |
2018-01-16 Exercise | 2018-01-18 9:30 pm | N/A 2024-09-08 | Juno Therapeutics Inc. | JUNO | Bishop Hans Edgar CEO | 245,750 | $0 | 2,954,185 (Direct) | View |
2018-01-16 Exercise | 2018-01-18 9:30 pm | N/A N/A | Juno Therapeutics Inc. | JUNO | Bishop Hans Edgar CEO | 245,750 | $6.36 | 2,954,185 (Direct) | View |
2017-10-20 Option Award | 2017-10-20 8:25 pm | N/A N/A | Juno Therapeutics Inc. | JUNO | Bishop Hans Edgar CEO | 35,893 | $0 | 2,526,929 (Direct) | View |
2017-07-18 Option Award | 2017-07-18 6:29 pm | N/A N/A | AGILENT TECHNOLOGIES INC | A | Bishop Hans Edgar Director | 2,199 | $61.21 | 2,199 (Direct) | View |